延期与分期组织扩张器联合游离皮瓣乳房再造的手术并发症比较
该回顾性研究比较了2010至2018年间接受延期(n=140,72%)与分期(n=54,28%)腹部游离皮瓣乳房再造患者的术后并发症。分期再造组围手术期并发症总体发生率更高,包括手术部位感染、伤口愈合问题、血肿和重返手术室,但这些并发症主要发生在扩张阶段,导致18.5%的组织扩张器失败。在皮瓣再造时,两组并发症发生率无显著差异。
要点
- 分期再造组围手术期并发症总体发生率高于延期组。
- 分期组并发症主要发生在组织扩张阶段,扩张器失败率为18.5%。
- 皮瓣再造时两组微血管并发症、皮瓣完全坏死和脂肪坏死无显著差异。
核心结论
- 分期游离皮瓣乳房再造的美学和社会心理益处需与其较高的围手术期并发症风险相权衡。
- 确定性皮瓣再造相关并发症似乎不受乳房切除术时所采取策略的影响。
研究设计与样本
- 回顾性研究,纳入2010至2018年间接受腹部游离皮瓣乳房再造的患者。
- 延期组140例(72%),分期组54例(28%)。
主要发现
- 分期组手术部位感染发生率40.7% versus 延期组6.5%(p < 0.001)。
- 分期组伤口愈合并发症发生率29.6% versus 12.3%(p = 0.004)。
- 分期组血肿发生率11.1% versus 0.7%(p < 0.001)。
- 分期组重返手术室率27.8% versus 4.4%(p < 0.0001)。
- 分期组组织扩张器失败率为18.5%(n = 10)。
临床怎么用
- 对于不适合立即游离皮瓣再造的患者,选择延期或分期方案时需告知分期方案围手术期并发症风险较高,尤其是扩张阶段。
- 分期方案的组织扩张器失败率需在术前咨询中说明。
局限性
- 回顾性研究设计。
- 证据等级为治疗性III级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients undergoing mastectomy may not be candidates for immediate free-flap breast reconstruction because of medical comorbidities or postmastectomy radiation therapy. In this setting, flap reconstruction may be intentionally delayed or staged with tissue expander placement ("delayed-immediate" reconstruction). The optimal reconstructive choice and incidence of complications for these approaches remain unclear. METHODS: The authors retrospectively identified patients who underwent delayed [n = 140 (72 percent)] or staged [n = 54 (28 percent)] abdominal free-flap breast reconstruction between 2010 and 2018 and compared the incidence of postoperative complications. RESULTS: Patients undergoing staged reconstruction had a higher overall incidence of perioperative complications, including surgical-site infection (40.7 percent versus 6.5 percent; p < 0.001), wound healing complications (29.6 percent versus 12.3 percent; p = 0.004), hematoma (11.1 percent versus 0.7 percent; p < 0.001), and return to the operating room (27.8 percent versus 4.4 percent; p < 0.0001). These complications occurred predominately during the expansion stage, resulting in an 18.5 percent (n = 10) rate of tissue expander failure. Mean time from mastectomy to flap reconstruction was 476.8 days (delayed, 536.4 days; staged, 322.4 days; p < 0.001). At the time of flap reconstruction, there was no significant difference in the incidence of complications between the staged cohort versus the delayed cohort, including microsurgical complications (1.9 percent versus 4.3 percent; p = 0.415), total flap loss (0 percent versus 2.1 percent; p = 0.278), or fat necrosis (5.6 percent versus 5.0 percent; p = 0.875). CONCLUSIONS: The aesthetic and psychosocial benefits of staged free-flap breast reconstruction should be balanced with the increased risk of perioperative complications as compared to a delayed approach. Complications related to definitive flap reconstruction do not appear to be affected by the approach taken at the time of mastectomy. . CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.
引用
- Shammas RL, Cason RW, Sergesketter AR, et al. A Comparison of Surgical Complications in Patients Undergoing Delayed versus Staged Tissue-Expander and Free-Flap Breast Reconstruction. Plast Reconstr Surg. 2021. PMID: 34270511. doi:10.1097/PRS.0000000000008208
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。